Navigation Links
Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Date:11/5/2008

study in colon

cancer, with the goal of reporting results in 2009.

Peer-Reviewed Publications and Medical Meeting Presentations

-- Two abstracts were accepted for oral presentation at the San Antonio

Breast Cancer Symposium in December 2008:

-- "Risk of distant recurrence using Oncotype DX in postmenopausal

primary breast cancer patients treated with anastrozole or

tamoxifen: a TransATAC study"

-- "GRB7-dependent pathways are potential therapeutic targets in

triple-negative breast cancer"

-- The American Journal of Surgery published results of a study showing

Oncotype DX changed treatment recommendations in 44 percent of node-

negative, estrogen receptor-positive breast cancer patients.

-- Presented results from two studies supporting the use of Oncotype DX in

assessing HER2 gene expression at the ASCO Breast Cancer Symposium in

September.

-- Independent researchers presented results from a small study of

Japanese women demonstrating that the Oncotype DX Recurrence Score(R)

result may predict response to neoadjuvant endocrine therapy including

tamoxifen and anastrozole at the ASCO Breast Cancer Symposium in

September.

Conference Call Details

To access the live conference call today, November 5, at 4:30 p.m. Eastern Time via phone, please dial (877) 356-8064 from the United States and Canada or (706) 758-4314 internationally. The conference ID is 71000165. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 12 and may be accessed by dialing (800) 642-1687 from the United States and Canada or (706) 645-9291 internationally. The replay passcode is 71000165.

To access the live and subsequently archived webcast of the conference call, go to the Invest
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Oro Valley, Arizona (PRWEB) September 16, 2014 ... company that develops safe and effective products to ... through the use of a proprietary SPACEā„¢ Technology ... Executive Officer and President will present at the ... 18, 2014 at the Hyatt Regency Phoenix. ...
(Date:9/16/2014)... 2014  Ascendis Pharma A/S, a biotechnology company ... significant unmet medical needs, today announced positive interim ... to evaluate once-weekly TransCon Growth Hormone in children ... interim results will be presented at the 7th ... being held October 15-18, 2014, in Singapore.  ...
(Date:9/16/2014)... Canada (PRWEB) September 16, 2014 According ... the Toronto affiliate of ITRA Global, new development in ... the Toronto city council approving another 755 storeys of ... it appears construction cranes will be dominating the Toronto ... seems to have an unquenchable thirst for new development. ...
(Date:9/15/2014)... , Sept. 15, 2014   Global ... innovator of scientific products and services for satellite ... Acquisition Solution for Integrated Services (OASIS) from the ... GST was selected to provide the government best-value ... Small Business (SB) category in Pool 4. The ...
Breaking Biology Technology:Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3
... results in physician,s office -, MADISON, N.J., ... Quest Diagnostics Incorporated (NYSE: DGX ),today announced ... T(TM) fecal,immunochemical test, a point-of-care version of the ... the sensitivity and,specificity of the laboratory-based InSure FIT ...
... Announces CE Mark Approval for First Product, the CorMatrix ... ECM(TM) for ... an,Atlanta- based company dedicated to developing and delivering unique,extracellular matrix ... damaged cardiovascular tissue, announced,today that the company has received 510(k) ...
... Pursues Strategy of Reducing Heart Attack Deaths by Shielding ... High-Risk Plaques ... Prescient Medical, Inc., a,privately held medical device company dedicated ... results on the chemical,characterization and treatment of rupture-prone or ...
Cached Biology Technology:Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening 2Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening 3Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening 4Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening 5CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair 2CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair 3CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair 4Prescient Medical, Inc. to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008 2
(Date:9/16/2014)... year, a new football season and another commercial cargo ... Dragon spacecraft is scheduled to blast off to the ... the company,s fourth contracted mission to the complex. , ... of research investigations sponsored by the Center for the ... of managing the U.S. National Laboratory on the space ...
(Date:9/16/2014)... A complex web of interaction between viruses, bacteria, ... by a growing international collaboration between Matthew Sullivan, ... of Ecology and Evolutionary Biology and Steven Hallam ... Canada. , "Bacteria are drivers of nutrient ... said. "As the climate is changing, so are ...
(Date:9/16/2014)... (KXL) would likely increase oil sands extraction, according to ... non-profit organization Near Zero. The results are detailed in ... both supporters and opponents of the pipeline. ... to significantly higher greenhouse gas emissions, with the exact ... "This report examines three main scenarios discussed by participants ...
Breaking Biology News(10 mins):CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3New research decodes virus-host interactions in ocean dead zones 2New research decodes virus-host interactions in ocean dead zones 3Keystone XL would likely raise oil sands production and greenhouse gas emissions 2
... the University of California, Riverside are part of a ... living bacteria a discovery that could help in ... The research team believes this is the first ... biological rather than chemical means. It opens the door ...
... teaming up with colleagues in other higher education institutions ... courses. They include research into a mobile biosensor, ... sports, and a manufacturing process to make titanium golf ... seven collaborative studentships, currently underway in the East Midlands. ...
... a diesel engine is far from easy. Due to ... combustion cycles are the same. Furthermore, the measurements are ... is injected into the cylinder causes an extra source ... cylinder with an engine adapted for this purpose. ...
Cached Biology News:Nanotube-producing bacteria show manufacturing promise 2
... Plates are designed for quick and easy ... plates feature two 0.25mm holes laser cut ... The wells remain liquid-tight during incubation of ... time the protein diffuses from the gel ...
... is a direct antibiotic-based ... identification. Recombinant selection depends ... eliminating the need for ... quick and inexpensive process ...
... Enhancer does for enzyme-/substrate-based blotting what intensifying screens ... signal up to 10-fold (or one order of ... Blot Signal Enhancer membrane treatment is a simple, ... your current Western blotting protocol. The result is ...
... a multi-functional program that searches ... a sequence file for polymerase ... site-directed mutagenesis, and various hybridization ... and secondary structure of oligonucleotides ...
Biology Products: